bladder cancer

Showing NaN - NaN of 57

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Australia, New Zealand, United Kingdom (WBRT, SART, DART)

Active, not recruiting
  • Bladder Cancer
  • WBRT
  • +2 more
  • Wagga Wagga, New South Wales, Australia
  • +48 more
Jun 5, 2020

Urinary Bladder Cancer, Bladder Cancer, Bladder Tumors Trial in Canada, United States (Vicinium)

Completed
  • Urinary Bladder Cancer
  • +3 more
  • Tallahassee, Florida
  • +20 more
Apr 30, 2020

Bladder Cancer Trial in Canada (biological, drug, procedure)

Terminated
  • Bladder Cancer
  • BCG vaccine
  • +2 more
  • Vancouver, British Columbia, Canada
  • +5 more
Apr 1, 2020

Bladder Cancer Trial in United Kingdom (Mitomycin C, Surgical Management)

Unknown status
  • Bladder Cancer
  • Mitomycin C
  • Surgical Management
  • Macclesfield, Cheshire, United Kingdom
  • +37 more
Mar 17, 2020

Bladder Cancer Trial in Worldwide (MPDL3280A)

Unknown status
  • Bladder Cancer
  • Bordeaux, France
  • +19 more
Feb 24, 2020

To Detect the Sensitivity of the UroMark Assay

Unknown status
  • Bladder Cancer
    • Ashton-under-Lyne, United Kingdom
    • +18 more
    Oct 8, 2019

    The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

    Unknown status
    • Bladder Cancer
    • Cx bladder Monitor test
    • London, Ontario, Canada
      Victoria Hospital
    Aug 12, 2019

    Bladder Cancer Trial in Worldwide (Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody, Docetaxel,

    Completed
    • Bladder Cancer
    • Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody
    • +3 more
    • Washington, District of Columbia
    • +216 more
    Jul 5, 2019

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,

    Completed
    • Bladder Cancer
    • +3 more
    • Glasgow, Scotland, United Kingdom
    • +20 more
    May 14, 2019

    Bladder Cancer Trial in London, Middlesbrough (Group)

    Completed
    • Bladder Cancer
    • Group
    • London, United Kingdom
    • +1 more
    Apr 16, 2019

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United Kingdom (cisplatin,

    Completed
    • Bladder Cancer
    • +2 more
    • Bristol, Avon, United Kingdom
    • +15 more
    Oct 25, 2018

    Urothelial Cancer, Bladder Cancer, Adult Trial in Canada (SU011248, Placebo)

    Completed
    • Urothelial Cancer
    • +2 more
    • Calgary, Alberta, Canada
    • +4 more
    Aug 20, 2018

    Bladder Cancer Trial in Canada, Poland, United States (Apaziquone, Placebo, TURBT)

    Completed
    • Bladder Cancer
    • Anaheim, California
    • +76 more
    Oct 10, 2017

    NMP22 Provides Improved Sensitivity in Detecting Bladder

    Completed
    • Bladder Cancer
    • Nuclear Matrix Protein 22 Urine sample kit
    • London, Ontario, Canada
      London Health Sciences Centre
    Aug 24, 2017

    Anal Cancer, Bladder Cancer, Cervical Cancer Trial in London (dietary supplement, other, procedure, radiation)

    Completed
    • Anal Cancer
    • +8 more
    • dietary intervention
    • +4 more
    • London, England, United Kingdom
      Royal Marsden - London
    Oct 31, 2016

    Bladder Cancer Trial in United Kingdom (Standard planning radiotherapy, Adaptive planning radiotherapy)

    Active, not recruiting
    • Bladder Cancer
    • Standard planning radiotherapy
    • Adaptive planning radiotherapy
    • Cambridge, United Kingdom
    • +10 more
    Aug 9, 2016

    Bladder Cancer Trial in London (Metformin, Simvastatin)

    Unknown status
    • Bladder Cancer
    • London, Ontario, Canada
      London Health Sciences Center; Victoria Hospital
    Jul 7, 2016

    Bladder Cancer, Transitional Cell Carcinoma, Metastasis Trial in Worldwide (Vinflunine, Gemcitabine, Placebo)

    Completed
    • Bladder Cancer
    • +2 more
    • Birmingham, Alabama
    • +111 more
    Nov 6, 2015

    Bladder Cancer Trial in Canada, United States (tipifarnib)

    Completed
    • Bladder Cancer
    • Chicago, Illinois
    • +6 more
    Jul 22, 2015

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (bortezomib)

    Completed
    • Bladder Cancer
    • Transitional Cell Cancer of the Renal Pelvis and Ureter
    • Chicago, Illinois
    • +14 more
    Jul 22, 2015

    Bladder Cancer Trial in United Kingdom (lapatinib ditosylate, Placebo)

    Unknown status
    • Bladder Cancer
    • lapatinib ditosylate
    • Placebo
    • London, England, United Kingdom
    • +26 more
    Apr 14, 2015

    Bladder Cancer Trial in London (biological, drug, radiation)

    Completed
    • Bladder Cancer
    • BCG vaccine
    • +2 more
    • London, England, United Kingdom
      Middlesex Hospital- Meyerstein Institute
    Dec 17, 2013

    Bladder Cancer Trial in United Kingdom (fluorouracil, mitomycin C, radiation therapy)

    Completed
    • Bladder Cancer
    • Bath, England, United Kingdom
    • +26 more
    Dec 17, 2013

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Worldwide (fluorouracil)

    Completed
    • Bladder Cancer
    • +2 more
    • Porto Alegre, Rio Grande do Sul, Brazil
    • +61 more
    Dec 3, 2013

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (oxaliplatin)

    Completed
    • Bladder Cancer
    • Transitional Cell Cancer of the Renal Pelvis and Ureter
    • Chicago, Illinois
    • +13 more
    Sep 4, 2013